FDA Clears Roche Point-of-Care STI Tests
The FDA granted 510(k) clearance for Roche STI multiplex panels, enabling rapid diagnosis of chlamydia, gonorrhea, and Mycoplasma genitalium.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
